Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol vs Amantadine for Tremors in Parkinson's Disease
NCT07113015Completed
- Sponsor
- Multan Medical and Dental College
- Start
- Jul 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of propranolol in Parkinson's disease (PD) (2 arms), sponsored by Multan Medical and Dental College. Primary endpoint: Change in tremor severity at 12 weeks. Started Jul 2024; status: completed.
02
Drugs
propranolol
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07113015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07113015.